Newcells Biotech Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.53M
- Investors
-
9
Newcells Biotech General Information
Description
Developer of a biotechnology platform designed to develop in vitro cell-based assays for early drug discovery and development. The company's platform is focused on building models that closely mimic the physiology of the kidney, retina, liver, and lung that improve prediction of safety, pharmacology and efficacy in humans and commercialized kidney and retina platforms as best in class and development for launch stem cell-based models of the liver and lung, enabling researchers to research and test new drugs and screen potential drug molecules for efficacy and toxicity.
Contact Information
Website
www.newcellsbiotech.co.ukCorporate Office
- The Biosphere, Drayman's Way
- Newcastle Helix
- Newcastle Upon Tyne NE4 5BX
- England, United Kingdom
Corporate Office
- The Biosphere, Drayman's Way
- Newcastle Helix
- Newcastle Upon Tyne NE4 5BX
- England, United Kingdom
Newcells Biotech Timeline
Newcells Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 05-Dec-2024 | $1.53M | Completed | Generating Revenue | ||
| 8. Later Stage VC | 14-Feb-2024 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 23-Feb-2021 | Completed | Generating Revenue | |||
| 6. Grant | 01-Oct-2019 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 04-Jul-2018 | Completed | Generating Revenue | |||
| 4. Grant | 22-Aug-2017 | Completed | Generating Revenue | |||
| 3. Grant | 01-Oct-2016 | Completed | Generating Revenue | |||
| 2. Seed Round | 02-Sep-2015 | $239K | $239K | Completed | Generating Revenue | |
| 1. University Spin-Out | 15-Jan-2015 | Completed | Startup |
Newcells Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| H2 Ordinary | ||||||||
| H2 Ordinary | ||||||||
| H1 Ordinary | ||||||||
| H1 Ordinary | ||||||||
| G Ordinary | ||||||||
| G Ordinary | ||||||||
| F2 Ordinary | ||||||||
| F1 Ordinary | ||||||||
| E Ordinary | 723,141 | $0.000127 | $3.07 | $3.07 | 1x | $3.07 | 9.78% | |
| D2 Ordinary | 105,953 | $0.000127 | $1.79 | $1.79 | 1x | $1.79 | 1.43% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Newcells Biotech Comparisons
Industry
Financing
Details
Newcells Biotech Competitors (25)
One of Newcells Biotech’s 25 competitors is Ncardia, a Venture Capital-Backed company based in Leiden, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ncardia | Venture Capital-Backed | Leiden, Netherlands | ||||
| Capricor Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| FUJIFILM Cellular Dynamics | Formerly VC-backed | Madison, WI | ||||
| Lisata Therapeutics | Corporation | Basking Ridge, NJ | ||||
| Surrozen | Formerly VC-backed | South San Francisco, CA |
Newcells Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Newcells Biotech Patents
Newcells Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202204371-D0 | Fluid flow plate | Inactive | 28-Mar-2022 | ||
| CA-3228082-A1 | Fluid flow plate | Pending | 26-Aug-2021 | ||
| EP-4392542-A1 | Fluid flow plate | Inactive | 26-Aug-2021 | ||
| GB-202112237-D0 | Fluid flow plate | Pending | 26-Aug-2021 | ||
| GB-2610208-A | Fluid flow plate | Pending | 26-Aug-2021 | C12M41/00 |
Newcells Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Newcells Biotech Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| North East Finance | Venture Capital | Minority | ||
| North East Fund | Venture Capital | Minority | ||
| European Regional Development Fund (Brandenburg) | Government | Minority | ||
| Northern Venture Trust | Venture Capital | Minority | ||
| Mercia Ventures | Venture Capital | Minority |
Newcells Biotech FAQs
-
When was Newcells Biotech founded?
Newcells Biotech was founded in 2015.
-
Where is Newcells Biotech headquartered?
Newcells Biotech is headquartered in Newcastle Upon Tyne, United Kingdom.
-
What is the size of Newcells Biotech?
Newcells Biotech has 30 total employees.
-
What industry is Newcells Biotech in?
Newcells Biotech’s primary industry is Drug Discovery.
-
Is Newcells Biotech a private or public company?
Newcells Biotech is a Private company.
-
What is Newcells Biotech’s current revenue?
The current revenue for Newcells Biotech is .
-
How much funding has Newcells Biotech raised over time?
Newcells Biotech has raised $19.1M.
-
Who are Newcells Biotech’s investors?
North East Finance, North East Fund, European Regional Development Fund (Brandenburg), Northern Venture Trust, and Mercia Ventures are 5 of 9 investors who have invested in Newcells Biotech.
-
Who are Newcells Biotech’s competitors?
Ncardia, Capricor Therapeutics, FUJIFILM Cellular Dynamics, Lisata Therapeutics, and Surrozen are some of the 25 competitors of Newcells Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
